These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10534334

  • 21. Plasma protein C is a useful clinical marker for hepatic veno-occlusive disease (VOD) in stem cell transplantation.
    Iguchi A, Kobayashi R, Kaneda M, Kobayashi K.
    Pediatr Blood Cancer; 2010 Mar; 54(3):437-43. PubMed ID: 19911420
    [Abstract] [Full Text] [Related]

  • 22. Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation.
    Toh HC, McAfee SL, Sackstein R, Cox BF, Colby C, Spitzer TR.
    Bone Marrow Transplant; 1999 Oct; 24(8):891-5. PubMed ID: 10516702
    [Abstract] [Full Text] [Related]

  • 23. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [Abstract] [Full Text] [Related]

  • 24. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation.
    Cheuk DK, Wang P, Lee TL, Chiang AK, Ha SY, Lau YL, Chan GC.
    Bone Marrow Transplant; 2007 Nov; 40(10):935-44. PubMed ID: 17768390
    [Abstract] [Full Text] [Related]

  • 25. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
    Salat C, Holler E, Wolf C, Kolb HJ, Reinhardt B, Pihusch R, Krämling HJ, Heinemann V, Haller M, Hiller E.
    Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916
    [Abstract] [Full Text] [Related]

  • 26. Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome.
    Hassoun Z, Shah V, Lohse CM, Pankratz VS, Petrovic LM.
    Liver Transpl; 2004 Apr; 10(4):480-7. PubMed ID: 15048789
    [Abstract] [Full Text] [Related]

  • 27. Association of hepatic veno-occlusive disease with the acquired immunodeficiency syndrome.
    Buckley JA, Hutchins GM.
    Mod Pathol; 1995 May; 8(4):398-401. PubMed ID: 7567938
    [Abstract] [Full Text] [Related]

  • 28. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 29. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation.
    Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, Okuno T, Koyanagi I, Takada Y, Manabe T.
    Liver Transpl; 2006 Mar; 12(3):457-64. PubMed ID: 16498648
    [Abstract] [Full Text] [Related]

  • 30. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.
    Tanikawa S, Mori S, Ohhashi K, Akiyama H, Sasaki T, Kaku H, Hiruma K, Matsunaga T, Morita T, Sakamaki H.
    Bone Marrow Transplant; 2000 Oct; 26(8):881-6. PubMed ID: 11081389
    [Abstract] [Full Text] [Related]

  • 31. [Assessment of risk factors in the incidence of hepatic artery thrombosis in a consecutive series of 687 liver transplantations].
    Proposito D, Loinaz Segurola C, Garcia Garcìa I, Jimènez C, Gonzalez Pinto I, Gomez Sanz R, De La Cruz J, Moreno Gonzàlez E.
    Ann Ital Chir; 2001 Oct; 72(2):187-205. PubMed ID: 11552475
    [Abstract] [Full Text] [Related]

  • 32. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
    Azoulay D, Castaing D, Lemoine A, Hargreaves GM, Bismuth H.
    Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
    [Abstract] [Full Text] [Related]

  • 33. [Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
    Matsuoka S, Okamoto S, Ishida A, Wakui M, Watanabe R, Moriki T, Ikeda Y, Hirabayashi N.
    Rinsho Ketsueki; 1998 Feb; 39(2):139-45. PubMed ID: 9545827
    [Abstract] [Full Text] [Related]

  • 34. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C, Holler E, Göhring P, Poley S, Kolb HJ, Pihusch R, Reinhardt B, Krämling HJ, Haller M, Hiller E.
    Eur J Med Res; 1996 Nov 25; 1(12):571-4. PubMed ID: 9438165
    [Abstract] [Full Text] [Related]

  • 35. Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Lee SH, Yoo KH, Sung KW, Koo HH, Kwon YJ, Kwon MM, Park HJ, Park BK, Kim YY, Park JA, Im HJ, Seo JJ, Kang HJ, Shin HY, Ahn HS.
    Bone Marrow Transplant; 2010 Aug 25; 45(8):1287-93. PubMed ID: 20010866
    [Abstract] [Full Text] [Related]

  • 36. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation.
    Najima Y, Ohashi K, Miyazawa M, Nakano M, Kobayashi T, Yamashita T, Akiyama H, Sakamaki H.
    Am J Hematol; 2009 May 25; 84(5):298-301. PubMed ID: 19338041
    [Abstract] [Full Text] [Related]

  • 37. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
    Chiu KW, Chen YS, de Villa VH, Wang CC, Eng HL, Wang SH, Liu PP, Jawan B, Huang TL, Cheng YF, Chen CL.
    Hepatogastroenterology; 2005 May 25; 52(66):1825-7. PubMed ID: 16334785
    [Abstract] [Full Text] [Related]

  • 38. Defibrotide for the treatment of veno-occlusive disease after liver transplantation.
    Mor E, Pappo O, Bar-Nathan N, Shaharabani E, Shapira Z, Tur-Kaspa R, Ben-Ari Z.
    Transplantation; 2001 Oct 15; 72(7):1237-40. PubMed ID: 11602848
    [Abstract] [Full Text] [Related]

  • 39. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
    Carreras E, Rosiñol L, Terol MJ, Alegre A, de Arriba F, García-Laraña J, Bello JL, García R, León A, Martínez R, Peñarrubia MJ, Poderós C, Ribas P, Ribera JM, San Miguel J, Bladé J, Lahuerta JJ, Spanish Myeloma Group/PETHEMA.
    Biol Blood Marrow Transplant; 2007 Dec 15; 13(12):1448-54. PubMed ID: 18022574
    [Abstract] [Full Text] [Related]

  • 40. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT.
    Am J Surg Pathol; 2008 Oct 15; 32(10):1479-88. PubMed ID: 18708942
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.